Hadassah University Medical Center Hosts Bone Marrow Transplant Reunion
The bone marrow transplant recipients (18-month-old Muhamad and8-year-old Hala) with Hadassah's Dr. Amal Bishara, who manages theBone Marrow Registry; their donors (21-year-old Maharan and 42-year-old Muhamad), and Hadassah Tissue Typing Registry Staff
Two Israeli Arab children who received bone marrow transplants a year ago recently met with their Israeli Arab donors at a reunion hosted by the Hadassah University Medical Center.
The donors are 2 of 65 individuals who were found to be genetically matched to Arab patients in Israel and abroad, thanks to the Bone Marrow Registry created at Hadassah for Arab patients. Eleven of them have already donated their bone marrow and most of the transplantations proved successful.
Hadassah established the registry in October 2008 because 40 percent of Arab patients did not have potential donors and there was no registry for Arabs in the world. It has since been supported by Hadassah Austria and the Kahane Foundation in Austria.
Dr. Amal Bishara manages the registry, together with Prof. Chaim Brautbar, who founded the Hadassah Tissue Typing Unit, and Dr. Shoshana Israel, its current director. Over 15,000 Israeli Arabs joined the registry during more than 90 campaigns in Arab villages and cities in Israel. These campaigns included lectures in Arab colleges and public institutions, as well as ongoing advertisements in Israel's Arab media.
"This was a very moving occasion" said Dr. Bishara. "We are all grateful to the donors, who opened the possibility for new life for people they did not know at all."
Baby Muhamad with his donor, Maharan, and Maharan's mother
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>